Jerry Wang
Direttore Tecnico/Scientifico/R&S presso I-MAB
Provenienza dei contatti di primo grado di Jerry Wang
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
12
| Public Company | Pharmaceuticals: Major | 12 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Jerry Wang tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| DEUTSCHE BANK AG | Major Banks | Corporate Officer/Principal | |
| AERIE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
| CSPC PHARMACEUTICAL GROUP LTD. | Biotechnology | Director/Board Member | |
The American Institute of Certified Public Accountants
 The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services The American Institute of Certified Public Accountants provides vocational education in accounting. The company provides services to the accounting community, regulatory bodies, and other organizations. It also operates in Jersey City, Washington, and Lewisville. It was founded in 1887 and is headquartered in New York City, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED | Information Technology Services | Director/Board Member | |
JAFCO Investment (Asia Pacific) Ltd.
 JAFCO Investment (Asia Pacific) Ltd. Investment ManagersFinance JAFCO Investment (Asia Pacific) Ltd. (JAFCO ASIA) is a venture capital subsidiary of JAFCO Group Co., Ltd. founded in 1990. The firm is headquartered in Singapore. | Investment Managers | Director/Board Member | |
| HPGC RENMINTONGTAI PHARMACEUTICAL CORPORATION | Pharmaceuticals: Major | Director/Board Member | |
| SINPHAR PHARMACEUTICAL CO.,LTD. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
| Nanjing University | College/University | Undergraduate Degree | |
| University of Tamkang | College/University | Doctorate Degree | |
| Nanyang Technological University | College/University | Undergraduate Degree | |
Rock Mobile Corp.
 Rock Mobile Corp. Commercial Printing/FormsCommercial Services Rock Mobile Corp. creates and distributes music-centric entertainment services. The firm is a provider of entertainment services via internet, mobile internet and other mobile devices. It offers integrating and producing entertainment contents (including music and games, etc), constructing digital entertainment cloud platform and spreading its productions and services via internet, mobile internet, operators and mobile devices. The company was founded by Sam Duann and Joshua Maa in September 2002 and is headquartered in Guangzhou, China. | Commercial Printing/Forms | Chief Executive Officer | |
| Providence University | College/University | Undergraduate Degree | |
| Shenyang Pharmaceutical University | College/University | Doctorate Degree | |
| MYCENAX BIOTECH INC. | Biotechnology | Corporate Officer/Principal | |
| Chinese Pharmaceutical Association | Director/Board Member | ||
| China Pharmaceutical University | College/University | Corporate Officer/Principal | |
Themes Investment Management Ltd.
 Themes Investment Management Ltd. Investment ManagersFinance Themes Investment Management Ltd is a private equity firm founded in 2009. The firm is headquartered in Hong Kong. | Investment Managers | Corporate Officer/Principal | |
| CHANGZHOU QIANHONG BIOPHARMA CO.,LTD | Pharmaceuticals: Major | Director/Board Member | |
| FAR EAST HORIZON LIMITED | Finance/Rental/Leasing | Corporate Officer/Principal | |
Ascletis Biopharmaceutical (Hangzhou) Co. Ltd.
 Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. Medical SpecialtiesHealth Technology Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. engages in discovering and developing new treatments for cancer and infectious diseases. The firm is currently developing ALN-VSP, a systemically delivered RNAi therapeutic comprising of two siRNAs designed to target two genes critical for the growth and development of cancer cells. It provides services to the Chinese pharmaceutical markets. The company was founded by Jinxing Qi and Jinzi J. Wu in 2011 and is headquartered in Hangzhou, China. | Medical Specialties | Director/Board Member | |
| BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
| CELLULAR BIOMEDICINE GROUP, INC. | Biotechnology | Director/Board Member | |
| SYNCORE BIOTECHNOLOGY CO.,LTD | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Columbia Business School | College/University | Graduate Degree | |
Ally Bridge Group HK Ltd
 Ally Bridge Group HK Ltd Investment ManagersFinance Ally Bridge Group HK Ltd (Ally Bridge) is a private equity firm founded in 2011 by Frank Yu. The firm is headquartered in Hong Kong with additional office in the US. | Investment Managers | Corporate Officer/Principal | |
| BEIGENE, LTD. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Morningside Group (Holdings) Ltd.
 Morningside Group (Holdings) Ltd. Investment ManagersFinance Part of Morningside Group Ltd., the company is based in Shanghai, China. The Chinese company is involved in venture capital and private equity. | Investment Managers | Director/Board Member | |
CBC Group (Singapore) Pte. Ltd.
 CBC Group (Singapore) Pte. Ltd. Investment ManagersFinance CBC Group (Singapore) Pte. Ltd.(CBC Group) is a private equity firm founded in 2014 by Wei Fu. The firm is headquartered in Singapore with additional offices in New York, Hong Kong, Shanghai and Beijing and is wholly owned by CBC Group Investment Management Ltd. | Investment Managers | Chief Executive Officer | |
| Gt Healthcare Group | Founder | ||
| EVEREST MEDICINES LIMITED | Pharmaceuticals: Major | Chairman | |
| ASCLETIS PHARMA INC. | Biotechnology | Director/Board Member | |
I-MAB Biopharma Co., Ltd.
 I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology I-Mab Biopharma (Shanghai) Co., Ltd. engages in the development of biologics. It focuses on monoclonal antibodies or bi-specific antibodies in the areas of immuno-oncology and autoimmune diseases. The company was founded by Jingwu Zang in March 2017 and is headquartered in Shanghai, China. | Biotechnology | Director/Board Member Chief Executive Officer Sales & Marketing | |
| CBC Group Co., Ltd. | Chief Executive Officer | ||
| REMEGEN CO., LTD. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| AMRYT PHARMA PLC | Pharmaceuticals: Major | Director/Board Member | |
| C-Bridge Capital Investment Management Ltd. | Chief Executive Officer | ||
| Standard Chartered Business Consulting Beijing Co. Ltd. | Corporate Officer/Principal | ||
Everest Medicines II Ltd.
 Everest Medicines II Ltd. Pharmaceuticals: MajorHealth Technology Everest Medicines II Ltd. develops and commercializes pharmaceutical products. The private company is based in Road Town, Cayman Islands. | Pharmaceuticals: Major | Director/Board Member | |
| Everest Medicines (Singapore) Pte Ltd. | Director/Board Member | ||
| YSB INC. | Packaged Software | Director/Board Member | |
| JIANGSU GDK BIOLOGICAL TECHNOLOGY CO., LTD | Biotechnology | Director/Board Member | |
| Center For Drug Evaluation of NMPA | Chief Tech/Sci/R&D Officer | ||
Genuine Biotech Ltd.
 Genuine Biotech Ltd. BiotechnologyHealth Technology Genuine Biotech Ltd. engages in the development, manufacturing, and commercialization of innovative drugs for the treatment of viral, oncological, and cerebrovascular diseases. The company was founded in 2012 and is headquartered in Pingdingshan, China. | Biotechnology | Director/Board Member | |
Shanghai Innostar Biotechnology Co., Ltd.
 Shanghai Innostar Biotechnology Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Innostar Biotechnology Co., Ltd. engages in the provision of comprehensive research and development services for biopharmaceutical non-clinical research. Its services include early-stage drug discovery, clinical testing & translational research, non-clinical safety evaluation, non-clinical pharmacokinetic studies, and non-clinical pharmacodynamic studies. The company was founded on May 12, 2010 and is headquartered in Shanghai, China. | Miscellaneous Commercial Services | Director/Board Member | |
| China Medical University | College/University | Undergraduate Degree | |
Qilu Pharmaceutical Co., Ltd.
 Qilu Pharmaceutical Co., Ltd. Pharmaceuticals: GenericHealth Technology Qilu Pharmaceutical Co., Ltd. manufactures and markets generic drugs. It offers services in the areas of oncology, infections, cerebrovascular and cardiovascular, psychological and neurological system, respiratory system and ophthalmological diseases. The company was founded in 1958 and is headquartered in Jinan, China. | Pharmaceuticals: Generic | Sales & Marketing | |
| Fu Jen Catholic University | College/University | Undergraduate Degree Graduate Degree | |
| SUZHOU ZELGEN BIOPHARMACEUTICALS CO.,LTD. | Pharmaceuticals: Major | Director/Board Member |
Statistiche
Distribuzione geografica
| Cina | 25 |
| Taiwan | 7 |
| Hong Kong | 6 |
| Isole Cayman | 6 |
| Stati Uniti | 5 |
Settori
| Health Technology | 23 |
| Consumer Services | 10 |
| Finance | 8 |
| Commercial Services | 4 |
| Technology Services | 3 |
Posizioni
| Director/Board Member | 80 |
| Independent Dir/Board Member | 33 |
| Corporate Officer/Principal | 23 |
| Director of Finance/CFO | 10 |
| Undergraduate Degree | 10 |
Contatti più connessi
| Insiders | |
|---|---|
| Chia Hung Yang | 31 |
| Wei Fu | 21 |
| Pamela Klein | 19 |
| Shuai Chen | 19 |
| Chun Kwok Au | 14 |
| Rong Shao | 12 |
| Rajkumar Kannan | 11 |
| Yun Han Lin | 7 |
| Ruyi He | 7 |
| Yi Fei Zhu | 5 |
- Borsa valori
- Insiders
- Jerry Wang
- Connessioni Società
